BioCentury
ARTICLE | Financial News

Ambit amends IPO

May 6, 2013 7:00 AM UTC

Ambit Biosciences Corp., San Diego, Calif. Business: Cancer, Autoimmune, Inflammation Date announced: 5/2/13 Type: IPO To be raised: Up to $80.1 million Shares: 4.6 million Price: $13-$15 Underwriters...